CERo Therapeutics Holdings, Inc.
CERO
$0.04
$0.008.70%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.50% | 10.35% | -6.10% | -859.92% | 115.89% |
| Total Depreciation and Amortization | 1.21% | 1.91% | -0.67% | -5.31% | -4.27% |
| Total Amortization of Deferred Charges | -78.92% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.35% | -60.94% | 93.10% | 112.35% | -1,626.40% |
| Change in Net Operating Assets | -82.47% | 245.77% | -417.05% | -105.68% | 33.56% |
| Cash from Operations | -18.76% | 30.67% | -3.99% | -188.66% | 44.17% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 32.21% |
| Issuance of Common Stock | -- | -- | -59.47% | 901.80% | -64.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -11.94% | -- | -- | -- | -13.94% |
| Repurchase of Preferred Stock | -- | -- | 100.00% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -119.95% | -- | -- | -- | 78.43% |
| Cash from Financing | 141.96% | -47.67% | -56.94% | 325.16% | -40.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.91% | 32.63% | -201.30% | 3,633.90% | 80.10% |